Relay Therapeutics (NASDAQ:RLAY) Price Target Lowered to $23.00 at Stifel Nicolaus
Relay Therapeutics (NASDAQ:RLAY – Get Free Report) had its price objective decreased by equities researchers at Stifel Nicolaus from $27.00 to $23.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Several other equities analysts also recently issued reports on the company. Leerink Partners reduced their […]
Relay Therapeutics (NASDAQ:RLAY – Get Free Report) had its price objective decreased by equities researchers at Stifel Nicolaus from $27.00 to $23.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Several other equities analysts also recently issued reports on the company. Leerink Partners reduced their […]
